Anna Williams is a content specialist in the medical school’s Office of Communications. She writes news stories about basic science and clinical research, as well as events, education and faculty news. She holds a bachelor’s degree in journalism from New York University. email@example.com
Nearly 40 percent of patients with atopic dermatitis saw their disease completely or almost completely cleared with a new drug called dupilumab, according to a Northwestern Medicine clinical trial.